The Experts below are selected from a list of 484740 Experts worldwide ranked by ideXlab platform
Terry A Taylo - One of the best experts on this subject based on the ideXlab platform.
-
original research ed pharmacotherapy the Treatment satisfaction scale tss is a sensitive measure of Treatment Effectiveness for both patients and partners results of a randomized controlled trial with vardenafil
The Journal of Sexual Medicine, 2007Co-Authors: Raymond C Rose, Irwi Goldstei, Xingyue Huang, Keithe Angerte, Terry A TayloAbstract:ABSTRACT Introduction Erectile dysfunction (ED) Treatment studies do not routinely measure “Treatment Effectiveness,” a function of Treatment response (based on efficacy and tolerability) and Treatment satisfaction (both patient and partner satisfaction). The ED Treatment Satisfaction Scale (TSS) is a brief, comprehensive self-report measure of patient and partner satisfaction. Aim To measure, for the first time in an ED Treatment study, pre- and post-Treatment patient and partner satisfaction with the TSS. Methods A randomized, double-blind, placebo-controlled, parallel-group, multi-institutional comparison of the efficacy and safety of flexible-dose vardenafil was performed in 229 couples (treated man with ED >6 months and untreated woman partner aged ≥18 years without sexual dysfunction [defined as a total Female Sexual Function Index score >26.55]). Main Outcome Measures Couples completed the TSS throughout the trial. Couples also completed the modified Sexual Life Quality Questionnaire–Quality of Life domain (mSLQQ-QoL) and men completed the International Index of Erectile Function-erectile function domain (IIEF-EF). Analysis of covariance produced least squares (LS) mean domain scores. Post hoc Pearson correlation coefficients were calculated for patient and partner TSS scores, and for TSS scores with other outcomes. Results TSS domain scores increased from baseline to last observation carried forward (LOCF) in the vardenafil-treated men and untreated women partners, but exhibited little change for the placebo group ( P Conclusions The TSS detected that vardenafil was superior to placebo on Treatment satisfaction from both patient and partner perspectives. The TSS holds promise for evaluating “Treatment Effectiveness” by measuring more general Treatment satisfaction. Rosen R, Goldstein I, Huang X-Y, Bangerter K, and Taylor T. The Treatment satisfaction scale (TSS) is a sensitive measure of Treatment Effectiveness for both patients and partners: Results of a randomized controlled trial with vardenafil.
-
original research ed pharmacotherapyoriginal research ed pharmacotherapy the Treatment satisfaction scale tss is a sensitive measure of Treatment Effectiveness for both patients and partners results of a randomized controlled trial with vardenafil
The Journal of Sexual Medicine, 2007Co-Authors: Raymond C Rose, Irwi Goldstei, Xingyue Huang, Keithe Angerte, Terry A TayloAbstract:Introduction Erectile dysfunction (ED) Treatment studies do not routinely measure “Treatment Effectiveness,” a function of Treatment response (based on efficacy and tolerability) and Treatment satisfaction (both patient and partner satisfaction). The ED Treatment Satisfaction Scale (TSS) is a brief, comprehensive self-report measure of patient and partner satisfaction.
Raymond C Rose - One of the best experts on this subject based on the ideXlab platform.
-
original research ed pharmacotherapy the Treatment satisfaction scale tss is a sensitive measure of Treatment Effectiveness for both patients and partners results of a randomized controlled trial with vardenafil
The Journal of Sexual Medicine, 2007Co-Authors: Raymond C Rose, Irwi Goldstei, Xingyue Huang, Keithe Angerte, Terry A TayloAbstract:ABSTRACT Introduction Erectile dysfunction (ED) Treatment studies do not routinely measure “Treatment Effectiveness,” a function of Treatment response (based on efficacy and tolerability) and Treatment satisfaction (both patient and partner satisfaction). The ED Treatment Satisfaction Scale (TSS) is a brief, comprehensive self-report measure of patient and partner satisfaction. Aim To measure, for the first time in an ED Treatment study, pre- and post-Treatment patient and partner satisfaction with the TSS. Methods A randomized, double-blind, placebo-controlled, parallel-group, multi-institutional comparison of the efficacy and safety of flexible-dose vardenafil was performed in 229 couples (treated man with ED >6 months and untreated woman partner aged ≥18 years without sexual dysfunction [defined as a total Female Sexual Function Index score >26.55]). Main Outcome Measures Couples completed the TSS throughout the trial. Couples also completed the modified Sexual Life Quality Questionnaire–Quality of Life domain (mSLQQ-QoL) and men completed the International Index of Erectile Function-erectile function domain (IIEF-EF). Analysis of covariance produced least squares (LS) mean domain scores. Post hoc Pearson correlation coefficients were calculated for patient and partner TSS scores, and for TSS scores with other outcomes. Results TSS domain scores increased from baseline to last observation carried forward (LOCF) in the vardenafil-treated men and untreated women partners, but exhibited little change for the placebo group ( P Conclusions The TSS detected that vardenafil was superior to placebo on Treatment satisfaction from both patient and partner perspectives. The TSS holds promise for evaluating “Treatment Effectiveness” by measuring more general Treatment satisfaction. Rosen R, Goldstein I, Huang X-Y, Bangerter K, and Taylor T. The Treatment satisfaction scale (TSS) is a sensitive measure of Treatment Effectiveness for both patients and partners: Results of a randomized controlled trial with vardenafil.
-
original research ed pharmacotherapyoriginal research ed pharmacotherapy the Treatment satisfaction scale tss is a sensitive measure of Treatment Effectiveness for both patients and partners results of a randomized controlled trial with vardenafil
The Journal of Sexual Medicine, 2007Co-Authors: Raymond C Rose, Irwi Goldstei, Xingyue Huang, Keithe Angerte, Terry A TayloAbstract:Introduction Erectile dysfunction (ED) Treatment studies do not routinely measure “Treatment Effectiveness,” a function of Treatment response (based on efficacy and tolerability) and Treatment satisfaction (both patient and partner satisfaction). The ED Treatment Satisfaction Scale (TSS) is a brief, comprehensive self-report measure of patient and partner satisfaction.
Susan J Prichard - One of the best experts on this subject based on the ideXlab platform.
-
fuel Treatment Effectiveness in the context of landform vegetation and large wind driven wildfires
Ecological Applications, 2020Co-Authors: Susan J Prichard, Nicholas A Povak, Maureen C Kennedy, David W PetersonAbstract:Large wildfires (>50,000 ha) are becoming increasingly common in semiarid landscapes of the western United States. Although fuel reduction Treatments are used to mitigate potential wildfire effects, they can be overwhelmed in wind-driven wildfire events with extreme fire behavior. We evaluated drivers of fire severity and fuel Treatment Effectiveness in the 2014 Carlton Complex, a record-setting complex of wildfires in north-central Washington State. Across varied topography, vegetation, and distinct fire progressions, we used a combination of simultaneous autoregression (SAR) and random forest (RF) approaches to model drivers of fire severity and evaluated how fuel Treatments mitigated fire severity. Predictor variables included fuel Treatment type, time since Treatment, topographic indices, vegetation and fuels, and weather summarized by progression interval. We found that the two spatial regression methods are generally complementary and are instructive as a combined approach for landscape analyses of fire severity. Simultaneous autoregression improves upon traditional linear models by incorporating information about neighboring pixel burn severity, which avoids type I errors in coefficient estimates and incorrect inferences. Random forest modeling provides a flexible modeling environment capable of capturing complex interactions and nonlinearities while still accounting for spatial autocorrelation through the use of spatially explicit predictor variables. All Treatment areas burned with higher proportions of moderate and high-severity fire during early fire progressions, but thin and underburn, underburn only, and past wildfires were more effective than thin-only and thin and pile burn Treatments. Treatment units had much greater percentages of unburned and low severity area in later progressions that burned under milder fire weather conditions, and differences between Treatments were less pronounced. Our results provide evidence that strategic placement of fuels reduction Treatments can effectively reduce localized fire spread and severity even under severe fire weather. During wind-driven fire spread progressions, fuel Treatments that were located on leeward slopes tended to have lower fire severity than Treatments located on windward slopes. As fire and fuels managers evaluate options for increasing landscape resilience to future climate change and wildfires, strategic placement of fuel Treatments may be guided by retrospective studies of past large wildfire events.
-
fuel Treatment Effectiveness in forests of the upper atlantic coastal plain an evaluation at two spatial scales
Forest Ecology and Management, 2012Co-Authors: Roger D. Ottmar, Susan J PrichardAbstract:Abstract Fuel Treatment Effectiveness in Southern forests has been demonstrated using fire behavior modeling and observations of reduced wildfire area and tree damage. However, assessments of Treatment Effectiveness may be improved with a more rigorous accounting of the fuel characteristics. We present two case studies to introduce a relatively new approach to characterizing fuels and predicting potential fire behavior, fuel consumption, and emissions in Southern forests using the Fuel Characteristic Classification System (FCCS) and Consume. The first case study provides fine-scale ( Results from the fine-scale assessment indicate that fuel Treatments reduce reaction intensity, rate of spread, and flamelength by up to 58%, 57%, and 63%, respectively. Fuel loading of strata that control surface fire behavior (i.e., shrubs, grasses, fine woody fuels, and litter) range from 32.0 Mg ha−1 in the thinned, untreated unit to 8.5 Mg ha−1 in the unthinned unit treated with herbicides and prescribed fire. Based on model predictions, up to 80% less fuel would be consumed with concomitant reduction in emissions during a wildfire occurring in the treated units compared to the untreated unit. Assessments of potential fire behavior across the study area indicate that overall hazard is low to moderate for this forested landscape. However, localized areas of high surface fire and crown fire potential were identified. Plot- and stand-based modeling both suggest that the potential for high to extreme fire behavior exists for this landscape. Combined, the two case studies highlight the ability of the FCCS to represent measured fuel characteristics and predict differences in potential fire behavior resulting from fuel Treatments. Even small differences in fuel characteristics resulting from fuel Treatments or site variation could be detected, allowing the effects of both ecological processes and management actions to be quantified.
Xingyue Huang - One of the best experts on this subject based on the ideXlab platform.
-
original research ed pharmacotherapy the Treatment satisfaction scale tss is a sensitive measure of Treatment Effectiveness for both patients and partners results of a randomized controlled trial with vardenafil
The Journal of Sexual Medicine, 2007Co-Authors: Raymond C Rose, Irwi Goldstei, Xingyue Huang, Keithe Angerte, Terry A TayloAbstract:ABSTRACT Introduction Erectile dysfunction (ED) Treatment studies do not routinely measure “Treatment Effectiveness,” a function of Treatment response (based on efficacy and tolerability) and Treatment satisfaction (both patient and partner satisfaction). The ED Treatment Satisfaction Scale (TSS) is a brief, comprehensive self-report measure of patient and partner satisfaction. Aim To measure, for the first time in an ED Treatment study, pre- and post-Treatment patient and partner satisfaction with the TSS. Methods A randomized, double-blind, placebo-controlled, parallel-group, multi-institutional comparison of the efficacy and safety of flexible-dose vardenafil was performed in 229 couples (treated man with ED >6 months and untreated woman partner aged ≥18 years without sexual dysfunction [defined as a total Female Sexual Function Index score >26.55]). Main Outcome Measures Couples completed the TSS throughout the trial. Couples also completed the modified Sexual Life Quality Questionnaire–Quality of Life domain (mSLQQ-QoL) and men completed the International Index of Erectile Function-erectile function domain (IIEF-EF). Analysis of covariance produced least squares (LS) mean domain scores. Post hoc Pearson correlation coefficients were calculated for patient and partner TSS scores, and for TSS scores with other outcomes. Results TSS domain scores increased from baseline to last observation carried forward (LOCF) in the vardenafil-treated men and untreated women partners, but exhibited little change for the placebo group ( P Conclusions The TSS detected that vardenafil was superior to placebo on Treatment satisfaction from both patient and partner perspectives. The TSS holds promise for evaluating “Treatment Effectiveness” by measuring more general Treatment satisfaction. Rosen R, Goldstein I, Huang X-Y, Bangerter K, and Taylor T. The Treatment satisfaction scale (TSS) is a sensitive measure of Treatment Effectiveness for both patients and partners: Results of a randomized controlled trial with vardenafil.
-
original research ed pharmacotherapyoriginal research ed pharmacotherapy the Treatment satisfaction scale tss is a sensitive measure of Treatment Effectiveness for both patients and partners results of a randomized controlled trial with vardenafil
The Journal of Sexual Medicine, 2007Co-Authors: Raymond C Rose, Irwi Goldstei, Xingyue Huang, Keithe Angerte, Terry A TayloAbstract:Introduction Erectile dysfunction (ED) Treatment studies do not routinely measure “Treatment Effectiveness,” a function of Treatment response (based on efficacy and tolerability) and Treatment satisfaction (both patient and partner satisfaction). The ED Treatment Satisfaction Scale (TSS) is a brief, comprehensive self-report measure of patient and partner satisfaction.
Keithe Angerte - One of the best experts on this subject based on the ideXlab platform.
-
original research ed pharmacotherapy the Treatment satisfaction scale tss is a sensitive measure of Treatment Effectiveness for both patients and partners results of a randomized controlled trial with vardenafil
The Journal of Sexual Medicine, 2007Co-Authors: Raymond C Rose, Irwi Goldstei, Xingyue Huang, Keithe Angerte, Terry A TayloAbstract:ABSTRACT Introduction Erectile dysfunction (ED) Treatment studies do not routinely measure “Treatment Effectiveness,” a function of Treatment response (based on efficacy and tolerability) and Treatment satisfaction (both patient and partner satisfaction). The ED Treatment Satisfaction Scale (TSS) is a brief, comprehensive self-report measure of patient and partner satisfaction. Aim To measure, for the first time in an ED Treatment study, pre- and post-Treatment patient and partner satisfaction with the TSS. Methods A randomized, double-blind, placebo-controlled, parallel-group, multi-institutional comparison of the efficacy and safety of flexible-dose vardenafil was performed in 229 couples (treated man with ED >6 months and untreated woman partner aged ≥18 years without sexual dysfunction [defined as a total Female Sexual Function Index score >26.55]). Main Outcome Measures Couples completed the TSS throughout the trial. Couples also completed the modified Sexual Life Quality Questionnaire–Quality of Life domain (mSLQQ-QoL) and men completed the International Index of Erectile Function-erectile function domain (IIEF-EF). Analysis of covariance produced least squares (LS) mean domain scores. Post hoc Pearson correlation coefficients were calculated for patient and partner TSS scores, and for TSS scores with other outcomes. Results TSS domain scores increased from baseline to last observation carried forward (LOCF) in the vardenafil-treated men and untreated women partners, but exhibited little change for the placebo group ( P Conclusions The TSS detected that vardenafil was superior to placebo on Treatment satisfaction from both patient and partner perspectives. The TSS holds promise for evaluating “Treatment Effectiveness” by measuring more general Treatment satisfaction. Rosen R, Goldstein I, Huang X-Y, Bangerter K, and Taylor T. The Treatment satisfaction scale (TSS) is a sensitive measure of Treatment Effectiveness for both patients and partners: Results of a randomized controlled trial with vardenafil.
-
original research ed pharmacotherapyoriginal research ed pharmacotherapy the Treatment satisfaction scale tss is a sensitive measure of Treatment Effectiveness for both patients and partners results of a randomized controlled trial with vardenafil
The Journal of Sexual Medicine, 2007Co-Authors: Raymond C Rose, Irwi Goldstei, Xingyue Huang, Keithe Angerte, Terry A TayloAbstract:Introduction Erectile dysfunction (ED) Treatment studies do not routinely measure “Treatment Effectiveness,” a function of Treatment response (based on efficacy and tolerability) and Treatment satisfaction (both patient and partner satisfaction). The ED Treatment Satisfaction Scale (TSS) is a brief, comprehensive self-report measure of patient and partner satisfaction.
